| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Ehud Gazit | Q172151 |
| P2093 | author name string | Dov Lichtenberg | |
| Hila Shoval | |||
| P2860 | cites work | Lipid peroxidation in the presence of albumin, inhibitory and prooxidative effects | Q45204045 |
| Critical balance of electrostatic and hydrophobic interactions is required for beta 2-microglobulin amyloid fibril growth and stability | Q45235968 | ||
| Phenolics as potential antioxidant therapeutic agents: mechanism and actions | Q46205891 | ||
| Radical scavenging capacity of wine anthocyanins is strongly pH-dependent | Q46584093 | ||
| Hydrogen peroxide is generated during the very early stages of aggregation of the amyloid peptides implicated in Alzheimer disease and familial British dementia. | Q46685854 | ||
| beta-Amyloid peptides induce degeneration of cultured rat microglia | Q46885770 | ||
| Structural and kinetic features of amyloid beta-protein fibrillogenesis | Q47758213 | ||
| Lipid oxidation in unfractionated serum and plasma | Q47773002 | ||
| Irreversible dimerization/tetramerization and post-translational modifications inhibit proteolytic degradation of A beta peptides of Alzheimer's disease | Q47962016 | ||
| Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion | Q48142442 | ||
| Assembly of A beta amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease | Q48157079 | ||
| Characterization of neuronal dystrophy induced by fibrillar amyloid beta: implications for Alzheimer's disease. | Q48495532 | ||
| A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. | Q48725577 | ||
| The toxicity of the Alzheimer's beta-amyloid peptide correlates with a distinct fiber morphology. | Q50528215 | ||
| Inhibition of amyloid beta protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger. | Q53211552 | ||
| Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis. | Q53222718 | ||
| Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides. | Q53265841 | ||
| Rapid induction of Alzheimer A beta amyloid formation by zinc. | Q53316140 | ||
| Thermodynamics of chelation by tetracyclines. | Q54665505 | ||
| Characterization of Copper Interactions with Alzheimer Amyloid β Peptides | Q57080882 | ||
| Molecular dynamics simulation of the aggregation of the core-recognition motif of the islet amyloid polypeptide in explicit water | Q57795191 | ||
| Electron Microscopic Observations on a Fibrous Component in Amyloid of Diverse Origins | Q59092070 | ||
| Antioxidant activity applying an improved ABTS radical cation decolorization assay | Q33865975 | ||
| Isolation and characterization of novel benzoates, cinnamates, flavonoids, and lignans from Riesling wine and screening for antioxidant activity. | Q33951764 | ||
| Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. | Q34082498 | ||
| A possible role for pi-stacking in the self-assembly of amyloid fibrils | Q34107552 | ||
| Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum? | Q34183637 | ||
| Vitamin E and donepezil for the treatment of mild cognitive impairment | Q34411313 | ||
| Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases | Q34422461 | ||
| Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases | Q34443878 | ||
| The mechanism of action of antioxidants against lipoprotein peroxidation, evaluation based on kinetic experiments | Q34604584 | ||
| Peptide inhibitors of beta amyloid aggregation | Q34609352 | ||
| Senile plaque composition and posttranslational modification of amyloid-beta peptide and associated proteins | Q34750660 | ||
| Conformational changes preceding amyloid-fibril formation of amyloid-beta and stefin B; parallels in pH dependence | Q34946397 | ||
| The metallobiology of Alzheimer's disease | Q35104793 | ||
| A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease | Q35166007 | ||
| Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. | Q35969894 | ||
| Methionine oxidation by reactive oxygen species: reaction mechanisms and relevance to Alzheimer's disease | Q36023866 | ||
| The molecular pathology of Alzheimer's disease | Q36490940 | ||
| The transport of tetracyclines across the mouse ileum in vitro: the effect of cations and other agents | Q39098936 | ||
| Vitamin A exhibits potent antiamyloidogenic and fibril-destabilizing effects in vitro | Q40513419 | ||
| Alzheimer's disease and soluble A beta | Q40580706 | ||
| Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease | Q40635431 | ||
| The C-terminus of the beta protein is critical in amyloidogenesis | Q40779575 | ||
| Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc | Q40881389 | ||
| Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? | Q40918121 | ||
| Structure-antioxidant activity relationships of flavonoids and phenolic acids | Q41067074 | ||
| Synergistic activation of tyrosine phosphorylation by o-vanadate plus calcium ionophore A23187 or aromatic 1,2-diols | Q41487852 | ||
| Production of the Alzheimer amyloid beta protein by normal proteolytic processing | Q41599298 | ||
| Bidirectional amyloid fiber growth for a yeast prion determinant. | Q43553476 | ||
| New evidence that the Alzheimer beta-amyloid peptide does not spontaneously form free radicals: an ESR study using a series of spin-traps. | Q43615257 | ||
| Inhibition of beta-amyloid(40) fibrillogenesis and disassembly of beta-amyloid(40) fibrils by short beta-amyloid congeners containing N-methyl amino acids at alternate residues | Q43667956 | ||
| Influence of vitamin E and C supplementation on lipoprotein oxidation in patients with Alzheimer's disease | Q43680826 | ||
| The influence of pH on antioxidant properties and the mechanism of antioxidant action of hydroxyflavones | Q43755845 | ||
| Oxidation of methionine 35 attenuates formation of amyloid beta -peptide 1-40 oligomers | Q43931371 | ||
| Dietary intake of antioxidants and risk of Alzheimer disease | Q44036285 | ||
| Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study | Q44036291 | ||
| Methionine 35 oxidation reduces fibril assembly of the amyloid abeta-(1-42) peptide of Alzheimer's disease | Q44116115 | ||
| Antioxidant vitamin intake and risk of Alzheimer disease | Q44311362 | ||
| Interactions of flavonoids with iron and copper ions: a mechanism for their antioxidant activity. | Q44319959 | ||
| Dityrosine Cross-Linked Aβ Peptides: Fibrillar β-Structure in Aβ(1-40) Is Conducive to Formation of Dityrosine Cross-Links but a Dityrosine Cross-Link in Aβ(8-14) Does Not Induce β-Structure | Q44409265 | ||
| Screening pharmaceutical preparations containing extracts of turmeric rhizome, artichoke leaf, devil's claw root and garlic or salmon oil for antioxidant capacity. | Q44541638 | ||
| Different antioxidant effects of polyphenols on lipid peroxidation and hydroxyl radicals in the NADPH-, Fe-ascorbate- and Fe-microsomal systems | Q44593837 | ||
| Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro | Q44782704 | ||
| Analysis of flavonoids and other phenolic compounds using high-performance liquid chromatography with coulometric array detection: relationship to antioxidant activity | Q44986401 | ||
| Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Abeta oligomerization | Q45034193 | ||
| The effect of catechol O-methylation on radical scavenging characteristics of quercetin and luteolin--a mechanistic insight | Q45043361 | ||
| Anti-amyloidogenic activity of tannic acid and its activity to destabilize Alzheimer's beta-amyloid fibrils in vitro | Q45129121 | ||
| New Class of Inhibitors of Amyloid-beta Fibril Formation. IMPLICATIONS FOR THE MECHANISM OF PATHOGENESIS IN ALZHEIMER'S DISEASE | Q22248067 | ||
| The chemistry behind antioxidant capacity assays | Q28239864 | ||
| In vitro peroxidase oxidation induces stable dimers of beta-amyloid (1-42) through dityrosine bridge formation | Q28373696 | ||
| Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis | Q29547501 | ||
| Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins | Q29547593 | ||
| Beta edge strands in protein structure prediction and aggregation. | Q30335772 | ||
| NMR studies in aqueous solution fail to identify significant conformational differences between the monomeric forms of two Alzheimer peptides with widely different plaque-competence, A beta(1-40)(ox) and A beta(1-42)(ox). | Q30666112 | ||
| Analyzing microarray data using cluster analysis | Q30760338 | ||
| How curcumin works preferentially with water soluble antioxidants | Q30995432 | ||
| Plaque busters: strategies to inhibit amyloid formation in Alzheimer's disease | Q33702171 | ||
| Molecular basis for amyloid fibril formation and stability | Q33722932 | ||
| In vivo total antioxidant capacity: comparison of different analytical methods | Q33821061 | ||
| A molecular model of Alzheimer amyloid beta-peptide fibril formation | Q33859393 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 73-87 | |
| P577 | publication date | 2007-03-01 | |
| P1433 | published in | Amyloid | Q4749545 |
| P1476 | title | The molecular mechanisms of the anti-amyloid effects of phenols | |
| P478 | volume | 14 |
| Q50497689 | Amyloid aggregation of lysozyme: the synergy study of red wine polyphenols. |
| Q60932804 | Development and In Vitro Evaluation of Linear PEI-Shelled Heparin/Berberine Nanoparticles in Human Osteosarcoma U-2 OS Cells |
| Q36716434 | Diaryl hydrazones as multifunctional inhibitors of amyloid self-assembly |
| Q43197716 | Fibril growth kinetics reveal a region of beta2-microglobulin important for nucleation and elongation of aggregation |
| Q57364071 | Inhibiting, promoting, and preserving stability of functional proteinfibrils |
| Q46262746 | Inhibition of HEWL fibril formation by taxifolin: Mechanism of action. |
| Q60925231 | Olive Biophenols Reduces Alzheimer's Pathology in SH-SY5Y Cells and APPswe Mice |
| Q40284291 | Oxidized epigallocatechin gallate inhibited lysozyme fibrillation more strongly than the native form |
| Q26823798 | Physicochemical properties of cells and their effects on intrinsically disordered proteins (IDPs) |
| Q38086743 | Protein fibrillation and nanoparticle interactions: opportunities and challenges |
| Q24654711 | Silibinin prevents amyloid beta peptide-induced memory impairment and oxidative stress in mice |
| Q41894180 | Structure-activity relationships in peptide modulators of β-amyloid protein aggregation: variation in α,α-disubstitution results in altered aggregate size and morphology |
| Q43273763 | Study of cosolvent-induced alpha-chymotrypsin fibrillogenesis: does protein surface hydrophobicity trigger early stages of aggregation reaction? |
| Q51603221 | The Amyloid Fibril-Forming Properties of the Amphibian Antimicrobial Peptide Uperin 3.5. |
Search more.